Schmitz J E, Lifton M A, Reimann K A, Montefiori D C, Shen L, Racz P, Tenner-Racz K, Ollert M W, Forman M A, Gelman R S, Vogel C W, Letvin N L
Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, USA.
AIDS Res Hum Retroviruses. 1999 Jan 20;15(2):195-202. doi: 10.1089/088922299311619.
Cobra venom factor (CVF)-induced consumption of complement proteins was used to investigate the role of complement in vivo in the immunopathogenesis of simian immunodeficiency virus of macaques (SIVmac) infection in rhesus monkeys. Repeated administration of CVF was shown to deplete complement to <5% of baseline hemolytic activity of serum complement for 10 days in a normal monkey. Three groups of SIVmac-infected animals were then evaluated: monkeys treated with CVF resulting in complement depletion from days -1 to 10 postinfection, monkeys treated with CVF resulting in complement depletion from days 10 to 21 postinfection, and control monkeys that received no CVF. CD8+ SIVmac-specific cytotoxic T lymphocyte (CTL) generation and CD4+ T lymphocyte depletion during primary infection were not affected by CVF treatment. Viral load, assessed by measurements of plasma p27gag antigen and viral RNA, was transiently higher during the first 4 weeks following infection in the CVF-treated monkeys and the subsequent clinical course in these treated animals was accelerated. These results suggest that complement proteins may participate in immune defense mechanisms that decrease virus replication following the initial burst of intense viremia during primary SIVmac infection. However, we cannot rule out that the observed increased virus replication was induced by immune activation resulting from the administration of a foreign antigen to these monkeys.
眼镜蛇毒因子(CVF)诱导的补体蛋白消耗被用于研究补体在恒河猴感染猴免疫缺陷病毒(SIVmac)的免疫发病机制中的体内作用。在正常猴子中,重复给予CVF可使补体在10天内降至血清补体基线溶血活性的<5%。然后对三组感染SIVmac的动物进行评估:在感染后第-1天至第10天用CVF治疗导致补体耗竭的猴子,在感染后第10天至第21天用CVF治疗导致补体耗竭的猴子,以及未接受CVF的对照猴子。初次感染期间,CVF治疗对CD8+ SIVmac特异性细胞毒性T淋巴细胞(CTL)的产生和CD4+ T淋巴细胞的耗竭没有影响。通过测量血浆p27gag抗原和病毒RNA评估的病毒载量,在CVF治疗的猴子感染后的前4周内短暂升高,并且这些治疗动物随后的临床病程加速。这些结果表明,补体蛋白可能参与免疫防御机制,在原发性SIVmac感染期间强烈病毒血症的初始爆发后减少病毒复制。然而,我们不能排除观察到的病毒复制增加是由向这些猴子施用外来抗原引起的免疫激活所诱导的。